Zymo Research Receives CE IVD Mark for its Quick-DNA/RNA(TM) Viral MagBead Kit

Zymo Research Corp.

AsiaNet 86793

 

IRVINE, Calif., Nov. 23, 2020 /PRNewswire=KYODO JBN/--

 

-- Reliable and sensitive viral purification used for SARS-CoV-2 viral

detection and analysis

 

Zymo Research announced today that its Quick-DNA/RNA(TM) Viral MagBead Kit (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=2007182082&u=https%3A%2F%2Fwww.zymoresearch.com%2Fpages%2Fquick-viral-covid-19%3Futm_source%3DPRnewswire%26utm_medium%3DPress_Release%26utm_campaign%3Dviral_magbead_press_release_11.23.20%26utm_content%3DViral_Magbead_CE_IVD&a=Quick-DNA%2FRNA%E2%84%A2+Viral+MagBead+Kit

) was cleared for distribution to the European Union (EU) common market. The

product is designed for high-throughput purification of viral DNA and/or RNA

from biological samples that are stored in Zymo Research's DNA/RNA Shield (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=2593644175&u=https%3A%2F%2Fwww.zymoresearch.com%2Fpages%2Fdna-rna-shield-viral%3Futm_source%3DPRnewswire%26utm_medium%3DPress_Release%26utm_campaign%3Dviral_magbead_press_release_11.23.20%26utm_content%3DViral_Magbead_CE_IVD_shield&a=DNA%2FRNA+Shield

).(TM) DNA/RNA Shield(TM) is used for sample collection, nucleic acid

preservation, and inactivation of pathogens. The isolated high-quality nucleic

acids are ready for all downstream applications such as Next-Gen Sequencing and

RT-qPCR detection.

 

Photo -

https://mma.prnewswire.com/media/1340077/Zymo_Research_Quick_DNA_RNA_Viral_MagBead_Kit.jpg

 

 

Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg

 

 

"Zymo Research has played a significant role in combating the current COVID-19

pandemic," said Dr. Stanislav Forman, a scientist at Zymo Research. "All

products in our COVID-19 testing workflow are now CE IVD marked; thus, helping

our clinical customers in the EU and beyond."

 

The CE IVD marked Quick-DNA/RNA(TM) Viral MagBead Kit meets EU safety, health,

and environmental requirements. It can be used for the purification of viral

DNA/RNA, such as SARS-CoV-2, the virus that causes COVID-19, or other

pathogenic sample types. The kit is a part of several FDA EUA SARS-CoV-2 test

workflows developed by prominent companies such as Illumina and Fulgent

Genetics.

 

"We are very pleased that Zymo Research's Quick-DNA/RNA(TM) Viral MagBead Kit

has received the CE IVD Mark from the EU," said Thiago Pinto Nogueira, Veritas

Bio's (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=3690954961&u=https%3A%2F%2Fwww.veritasbio.com.br%2F&a=Veritas+Bio%27s

) Business Development Director. "In Brazil, our health regulatory agency

(ANVISA) welcomes products designated with the CE Mark. This facilitates our

work when we register products locally. To our customers, the mark indicates

this product has conformed with health and safety standards."

 

For more information about Zymo Research's Quick-DNA/RNA(TM) Viral MagBead Kit,

please visit their website (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=1964934647&u=https%3A%2F%2Fwww.zymoresearch.com%2Fproducts%2Fquick-dna-rna-viral-magbead%3Futm_source%3DPRnewswire%26utm_medium%3DPress_Release%26utm_campaign%3Dviral_magbead_press_release_11.23.20%26utm_content%3DViral_Magbead_CE_IVD_website&a=website

) or contact them via email at covid19requests@zymoresearch.com.

 

About Zymo Research Corp.

Zymo Research is a privately owned company that has been serving the scientific

and diagnostics community with state-of-the-art molecular biology tools since

1994. "The Beauty of Science is to Make Things Simple" is their motto, which is

reflected in all of their products, from epigenetics to DNA/RNA purification

technologies. Historically recognized as the leader in epigenetics, Zymo

Research is breaking boundaries with novel solutions for sample collection,

microbiomic measurements, diagnostic devices, and NGS technologies that are

high quality and simple to use. Follow Zymo Research on Facebook (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=2639836822&u=https%3A%2F%2Fwww.facebook.com%2Fzymoresearch&a=Facebook

), LinkedIn (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=996804232&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzymo-research-corp%2F&a=LinkedIn

), Twitter (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=4214065636&u=https%3A%2F%2Ftwitter.com%2FZymoResearch&a=Twitter

), and Instagram (

https://c212.net/c/link/?t=0&l=en&o=2989967-1&h=4173022034&u=https%3A%2F%2Fwww.instagram.com%2Fzymoresearch%2F&a=Instagram

).

 

 

SOURCE:  Zymo Research Corp.

 

CONTACT: Marketing Department

         Zymo Research Corp.

         +1-949-679-1190

         marketing@zymoresearch.com.

 

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中